Skip to main content
logo
Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
37.72
-1.34 (-3.43%)
At close: Mar 3, 2026, 4:00 PM EST
38.20
+0.48 (1.27%)
After-hours: Mar 3, 2026, 7:18 PM EST

Soleno Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,9472,4871,9381,2281633
Market Cap Growth
-12.02%28.31%57.88%7498.61%-50.63%-78.71%
Enterprise Value
1,4941,9831,6561,176-35
Last Close Price
37.7246.3044.9540.251.986.15
PE Ratio
96.72121.45----
Forward PE
9.4313.68----
PS Ratio
10.2313.06----
PB Ratio
4.385.537.917.791.561.84
P/TBV Ratio
4.375.598.138.25-6.35
P/FCF Ratio
41.6853.22----
P/OCF Ratio
41.6153.14----
EV/Sales Ratio
7.8510.42----
EV/EBITDA Ratio
88.04116.90----
EV/EBIT Ratio
99.92132.67----
EV/FCF Ratio
31.9742.45----
Debt / Equity Ratio
0.120.120.220.000.020.03
Debt / EBITDA Ratio
2.932.93----
Debt / FCF Ratio
1.131.13----
Net Debt / Equity Ratio
-1.01-1.01-1.08-1.07-1.40-1.17
Net Debt / EBITDA Ratio
-26.73-26.731.464.610.620.69
Net Debt / FCF Ratio
-9.71-9.713.846.790.700.75
Asset Turnover
0.430.43----
Quick Ratio
5.445.4415.5514.752.002.66
Current Ratio
5.805.8015.6814.892.142.80
Return on Equity (ROE)
6.01%6.01%-87.35%-46.45%-171.05%-97.60%
Return on Assets (ROA)
2.09%2.09%-45.06%-23.33%-50.58%-40.11%
Return on Capital Employed (ROCE)
3.00%3.00%-59.10%-22.90%-130.90%-117.10%
Earnings Yield
1.05%0.84%-9.07%-3.18%-148.97%-94.47%
FCF Yield
2.40%1.88%-3.58%-2.03%-128.71%-84.94%
Buyback Yield / Dilution
-30.39%-30.39%-143.61%-96.40%-57.90%-27.39%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q